Pharmaceutical companies are rushing to produce new weight loss drugs. But some of them come along with alarming side effects Continue reading
The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has learned that the FDA has published an analysis generally recommending caution when using popular bone-building medications for long terms, though without offering more specific suggestions. … Continue reading
According to the US Drug Watchdog, “We have a huge problem-hardly any young woman have heard about possible severe side effects associated with the birth control pills called Yaz, Yasmin, or generic version Ocella. … Continue reading
A new study suggests stem cells may be able to act as a shield to protect the body from the harmful side effects of chemotherapy, the BBC News reported. As chemotherapy drugs attempt to kill cancer drugs, they can also affect the bone marrow and other healthy tissues. Continue reading
click here to continue to article cliquez ici pour lire l’article weiter zum Artikel clicca qui per visualizzare l’articolo weiter zum Artikel ir a la noticia klik hier om door te gaan naar het artikel Yazya devam etmek iin tklayn Tovbb a cikkre Continue reading
The U.S. Food and Drug Administration says doctors need to reassess which women are likely to benefit from popular bone-building drugs, given the lack of evidence showing that taking them for the long term really helps and the possibility that they put some women at risk for rare but serious side effects. In a report published in the New England Journal of Medicine on Wednesday, the U.S. Continue reading
THURSDAY, May 10 (HealthDay News) — An advisory panel to the U.S. Food and Drug Administration on Thursday recommended approval of the weight-loss medication lorcaserin, even though concerns remain about cardiovascular side effects. Continue reading
It is increasingly recognized that chronic psychotropic drug treatment may lead to structural remodeling of the brain. Indeed, clinical studies in humans present an intriguing picture: antipsychotics, used for the treatment of schizophrenia and psychosis, may contribute to cortical gray matter loss in patients, whereas lithium, used for the treatment of bipolar disorder and mania, may preserve gray matter in patients. However, the clinical significance of these structural changes is not yet clear Continue reading
